An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).
If the findings are confirmed in more extensive clinical trials, the surgery could offer hope to patients with high blood pressure who do not respond to drugs, and are at increased risk of cardiovascular diseases, including stroke and heart attack.
The international clinical trial, carried out from 2017 to 2018 at St Bartholomew’s Hospital in the UK by the NIHRBarts Biomedical Research Centre, tested a one-hour operation called ‘renal denervation’, which uses ultrasound energy to disrupt the nerves between the kidneys and the brain that carry signals for controlling blood pressure.
Significant reduction in blood pressure
146 patients in the United States, France, Germany, the Netherlands, Belgium and the United Kingdom were randomised to receive either renal denervation or a ‘sham procedure’ – the surgical equivalent of a placebo. Patients also remained off blood pressure medications for two months unless specified blood pressure levels were exceeded.
After two months, the renal denervation group experienced an 8.5 mm Hg reduction in blood pressure, which was a 6.3 mm Hg greater reduction compared with the sham group.
More than 66 per cent of subjects treated with renal denervation demonstrated a 5 mm Hg or greater reduction in blood pressure, compared with 33 per cent in the sham group.
No major adverse events were reported in either group, and the blood pressure lowering effect of renal denervation was consistent across sex and ethnicity.
An alternative to lifelong medications
UK Principal Investigator Dr Melvin Lobo from Queen Mary’s William Harvey Research Institute and Barts Health NHS Trust said: “These results leave us clinicians in no doubt that this ultrasound-based therapy works to improve blood pressure control – at least in the short term. Further larger trials will be needed to confirm the efficacy and safety of the technology, but we hope that they could lead to renal denervation therapy being offered as an alternative to lifelong medications for hypertension.”
The study has limitations including the short follow-up time of two months. This was done for safety reasons to minimise the duration of patients being off antihypertensive medications. Longer follow-up of this trial and additional numbers of treated patients will be necessary to provide greater assurance of safety and to exclude rare adverse events.
Receive an email update when we add a new HYPERTENSION article.
The Latest on: Hypertension
via Google News
The Latest on: Hypertension
- Barbados not affected by recall of drug for hypertension on December 18, 2018 at 4:02 am
The Ministry of Health and Wellness has assured the public that Barbados has not been affected by the current recall of the hypertensive drug, Valsartan. The drug has been recalled due to an impurity ... […]
- High blood pressure - do you hear this noise in your ears? Hidden signs of hypertension on December 18, 2018 at 1:37 am
High blood pressure affects more than 25 per cent of all adults in the UK, according to the NHS. The condition, which is also known as hypertension, puts extra stress on blood vessels and vital organs ... […]
- Hypertension? Here's How Water Chestnuts Or Singhara May Help Manage BP on December 18, 2018 at 12:58 am
Water chestnuts are an excellent source of potassium. Did you know hundred grams of water chestnut has a whopping 584 grams of potassium? Potassium helps negate the ill-effects of sodium and maintain ... […]
- Study: Social determinants of health contribute to hypertension on December 17, 2018 at 10:53 am
Get all the latest industry news in your inbox. Higi, a population health enablement company with a national network of health stations in both urban and rural communities that empower consumers to me... […]
- IgA vasculitis linked to higher risk for hypertension, chronic kidney disease on December 17, 2018 at 2:49 am
Patients with IgA vasculitis, also known as Henoch-Schönlein purpura, are at an increased risk for hypertension and chronic kidney disease compared to those without the condition, according to recent ... […]
- Tooth loss related to hypertension risk in postmenopausal women on December 16, 2018 at 6:49 am
The presence of edentulism may serve as a significant warning sign for increased hypertension risk in postmenopausal women, according to findings published in the American Journal of Hypertension. Res... […]
- Hypertension can lead to blindness – Expert on December 15, 2018 at 4:00 pm
A health practitioner, Dr. Kayode Atoyebi, talks to TOPE OMOGBOLAGUN about hypertension What is blood pressure? It is the pressure at which blood moves in the body or pressure at which blood flows thr... […]
- Moderate or Severe Sleep Apnea Doubles Risk of Hard-to-Treat Hypertension in African-Americans on December 12, 2018 at 11:45 am
African-Americans with moderate or severe sleep apnea are twice as likely to have hard-to-control high blood pressure when their sleep apnea goes untreated, according to a new study funded mainly by t... […]
- Doubled Risk of Refractory Hypertension With Sleep Apnea in Blacks on December 10, 2018 at 2:38 pm
African-Americans with untreated sleep apnea were more than twice as likely to have hard-to-control hypertension as those without obstructive sleep apnea (OSA), according to an analysis of data from t... […]
via Bing News